Calculating cost per event avoided using a composite number needed to treat
This research illustrates the limitations of using a NNT focused only on the primary endpoint, as it does not capture the total benefit of the treatment. When considering the value of treatments through NNT or CPEA analyses, a composite endpoint capturing broader benefit should be utilized.
Authors
- J. Wang
- Joshua C. Toliver (ORCID: https://orcid.org/0000-0002-9159-2587)
- Jigish Bhavsar
- Sean D. Sullivan
Institutions
- University of Veterinary Medicine in Košice (SK)
- Novo Nordisk (United Kingdom) (GB)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1080/13696998.2026.2615606
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 99.81